Cue Biopharma, Inc is a US-based pharmaceutical company with a risk rating score of 28.2 (ESG score). Specializing in the development of biologic drugs for cancer and autoimmune diseases, Cue Biopharma aims to enhance therapeutic outcomes for patients. With a focus on environment, sustainability, and goverance, Cue Biopharma offers innovative drug products such as CUE-101 and CUE-102. Take advantage of Cue Biopharma's cutting-edge therapies for improved health.